Pathstone Holdings, LLC Neogenomics Inc Transaction History
Pathstone Holdings, LLC
- $22.2 Billion
- Q4 2024
A detailed history of Pathstone Holdings, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Pathstone Holdings, LLC holds 29,417 shares of NEO stock, worth $280,049. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,417
Previous 32,419
9.26%
Holding current value
$280,049
Previous $478,000
1.26%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding NEO
# of Institutions
282Shares Held
124MCall Options Held
751KPut Options Held
107K-
Black Rock Inc. New York, NY19.7MShares$187 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$136 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.53MShares$62.1 Million0.07% of portfolio
-
Janus Henderson Group PLC London, X06.17MShares$58.7 Million0.05% of portfolio
-
Brown Advisory Inc6.16MShares$58.6 Million0.13% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.2B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...